ArticleNPJ primary care respiratory medicine2018
Insights into frequent asthma exacerbations from a primary care perspective and the implications of UK National Review of Asthma Deaths recommendations.
Article in NPJ primary care respiratory medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Adverse Outcomes Associated With Short-Acting Beta-Agonist Overuse in Asthma: A Systematic Review and Meta-Analysis.Allergy · 2025Pooled it
- Review
- Guideline-driven and dependable management of asthma: an evidence-based systematic review.Annals of medicine and surgery (2012) · 2025Article
- Article
- Prevalence and predictors of annual asthma reviews in Scottish primary care data: an observational study.BJGP open · 2025Article
- Safety and Effectiveness of Allergen Immunotherapy in Patients with Severe Allergic Asthma.Journal of asthma and allergy · 2025Article
- How have we measured trial outcomes of asthma attack treatment? A systematic review.ERJ open research · 2024Article
- Predictors of excessive short-acting βPostepy dermatologii i alergologii · 2023Article
- Evaluation of short-acting Beta-2-agonist prescriptions and associated clinical outcomes: Findings from the SABA use IN Asthma (SABINA) study in Asia.The World Allergy Organization journal · 2023Article
- Effects of Ambient Air Pollutants on Hospital Admissions among Children Due to Asthma and Wheezing-Associated Lower Respiratory Infections in Mysore, India: A Time Series Study.Children (Basel, Switzerland) · 2023Article
- SABAs as Reliever Medications in Asthma Management: Evidence-Based Science.Advances in therapy · 2023Article
- Unmet Need for Oral Corticosteroids Use and Exacerbations of Asthma in Primary Care in Taiwan.Biomedicines · 2022Article
- Short-acting βNPJ primary care respiratory medicine · 2022Article
- Developing a Smartphone Application That Promotes Responsible Short-Acting Beta2-Agonist Use in People with Asthma: A Participatory Design.International journal of environmental research and public health · 2022Article
- Ambient Air Pollution and Risk of Admission Due to Asthma in the Three Largest Urban Agglomerations in Poland: A Time-Stratified, Case-Crossover Study.International journal of environmental research and public health · 2022Article
- Proposed Strategies to Improve Adult Asthma Management in Egypt: Expert Review and Recommendations.Annals of global health · 2022Review
- Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age.Advances in therapy · 2021Article
- Using routinely collected primary care records to identify and investigate severe asthma: a scoping review.NPJ primary care respiratory medicine · 2021Article
- High Use of SABAs is Associated with Higher Exacerbation Rate in Dutch Patients with Asthma.Journal of asthma and allergy · 2021Article
- A primary care database study of asthma among patients with and without opioid use disorders.NPJ primary care respiratory medicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The United Kingdom National Review of Asthma Deaths (NRAD) recommends that patients who require ≥3 courses of oral corticosteroids (OCS) for exacerbations in the past year or those on British Thoracic Society (BTS) Step 4/5 treatment must be referred to a specialist asthma service. The aim of the study was to identify the proportion of asthma patients in primary care that fulfil NRAD criteria for specialist referral and factors associated with frequent exacerbations. A total of 2639 adult asthma patients from 10 primary care practices in Glasgow, UK were retrospectively studied between 2014 and 2015. Frequent exacerbators and short-acting β
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.